Home » Stocks » PNTG

The Pennant Group, Inc. (PNTG)

Stock Price: $57.54 USD -5.68 (-8.98%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $57.54 0.00 (0.00%) Jan 15, 4:05 PM
Market Cap 1.62B
Revenue (ttm) 372.48M
Net Income (ttm) 7.93M
Shares Out 28.06M
EPS (ttm) 0.26
PE Ratio 221.31
Forward PE 61.73
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $57.54
Previous Close $63.22
Change ($) -5.68
Change (%) -8.98%
Day's Open 62.72
Day's Range 56.49 - 62.60
Day's Volume 174,677
52-Week Range 10.13 - 66.48

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 2 days ago

EAGLE, Idaho, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living service...

Seeking Alpha - 2 months ago

The Pennant Group's (PNTG) CEO Danny Walker on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

EAGLE, Idaho, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living service...

GlobeNewsWire - 2 months ago

EAGLE, Idaho, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, ...

GlobeNewsWire - 2 months ago

EAGLE, Idaho, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, ...

GlobeNewsWire - 2 months ago

EAGLE, Idaho, Oct. 29, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, ...

GlobeNewsWire - 3 months ago

EAGLE, Idaho, Oct. 02, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, ...

GlobeNewsWire - 3 months ago

EAGLE, Idaho, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, ...

GlobeNewsWire - 4 months ago

EAGLE, Idaho, Sept. 16, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companie...

Zacks Investment Research - 4 months ago

The Pennant Group, Inc. (PNTG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research - 4 months ago

3 Top Outpatient and Home Healthcare Stocks to Watch Out For

Other stocks mentioned: DVA, USPH
Seeking Alpha - 5 months ago

The Pennant Group, Inc. (PNTG) CEO Danny Walker on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 5 months ago

Conference Call and Webcast scheduled for tomorrow, August 12, 2020 at 10:00 am MT Conference Call and Webcast scheduled for tomorrow, August 12, 2020 at 10:00 am MT

GlobeNewsWire - 5 months ago

EAGLE, Idaho, Aug. 06, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living servi...

GlobeNewsWire - 6 months ago

EAGLE, Idaho, July 01, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies...

GlobeNewsWire - 7 months ago

EAGLE, Idaho, May 18, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies,...

Seeking Alpha - 8 months ago

The Pennant Group, Inc. (PNTG) CEO Danny Walker on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 8 months ago

Conference Call and Webcast scheduled for tomorrow, May 14, 2020 at 10:00 am MT Conference Call and Webcast scheduled for tomorrow, May 14, 2020 at 10:00 am MT

Seeking Alpha - 10 months ago

The Pennant Group, Inc. (PNTG) CEO Danny Walker on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

EAGLE, Idaho, Feb. 27, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies...

GlobeNewsWire - 1 year ago

EAGLE, Idaho, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies...

Forbes - 1 year ago

Reiterating ‘Buy’ The Pennant Group, Inc. (NASDAQ: PNTG; $32.18; Market Capitalization: $0.9 billion) is clearly among the best performing spin-offs in 2019.

About PNTG

The Pennant Group provides healthcare services in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, counseling, and palliative services for t... [Read more...]

Industry
Medical Care Facilities
Founded
2019
CEO
Daniel H. Walker
Employees
4,700
Stock Exchange
NASDAQ
Ticker Symbol
PNTG
Full Company Profile

Financial Performance

In 2019, Pennant Group's revenue was $338.53 million, an increase of 18.34% compared to the previous year's $286.06 million. Earnings were $2.55 million, a decrease of -83.77%.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Pennant Group stock is "Buy." The 12-month stock price forecast is 60.67, which is an increase of 5.44% from the latest price.

Price Target
$60.67
(5.44% upside)
Analyst Consensus: Buy